Power Wheelchair Group 3 denied due to quantity / dose limits by Humana?

Humana's specific coverage criteria for power wheelchair group3 are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Imposes Quantity Limits on Group 3 Power Wheelchairs — and When You Can Override Them

Humana's DME coverage policy generally limits members to one power mobility device per benefit period, and a request for a second device, a replacement within what Humana considers too short an interval, or an upgrade while a prior device is still on record will generate a quantity-limit denial for a Group 3 complex rehab power wheelchair. This limit is a default rule, not an absolute bar — Humana's own policy contains exception provisions for documented clinical change, irreparable equipment failure, or loss or theft.

## Why This Denial Is Appealable

Quantity-limit denials hinge on whether your circumstances fit an exception category. The appeal is about documenting the specific exception with clinical precision — not arguing that the limit is wrong. Common successful exception grounds include: the existing device is beyond economic repair (documented by a qualified technician); the member's functional needs have materially changed due to a new or progressed diagnosis; or the prior device was lost, stolen, or destroyed. Any of these, properly documented, can overturn the denial.

## Federal Appeal Framework

• Internal appeal: File within the deadline stated on the denial or EOB. Standard pre-service review: 30 days. Expedited (urgent): 72 hours. Post-service: 60 days.
• External review (ACA §2719): If Humana upholds the denial internally, file for independent external review within approximately four months. External reviewers consider whether Humana's application of its quantity limit was consistent with generally accepted clinical standards.
• ERISA §503: Employer-plan members have the right to the complete claim file. Request it — the file will clarify exactly which exception provision Humana considered and why it was rejected.

## Documentation to Gather

• Equipment condition report: A written assessment from a certified complex rehab technology supplier documenting the current device's condition and, where applicable, a formal determination that repair is not cost-effective.
• Clinical change documentation: Physician or specialist notes with specific dates documenting the change in diagnosis, functional status, or postural support needs that makes the prior device inadequate.
• New functional assessment: A physical or occupational therapy evaluation documenting the current functional profile and the Group 3 features now required that the prior device cannot provide.
• Prescriber medical-necessity letter: A letter linking the clinical change to the specific quantity-limit exception provision in Humana's policy, citing chart entries by date and provider.
• Humana's current coverage policy: Identify the exact exception language and build the appeal directly around it.

## Criteria-Mapping Structure

For each quantity-limit exception criterion in Humana's policy, provide a direct, dated, sourced chart entry confirming it is met. Submit the technician repair assessment and therapy evaluation as labeled exhibits. The goal is to show the reviewer that this is not a routine second-device request but a clinically documented exception — the narrower and more precisely you frame the argument, the harder it is to deny.